线性粒子加速器市场 - 产品类型、处理类型、应用、最终用户 - 全球预测

由于基于辐射的技术（包括医学成像、放射治疗和工业加工）的使用不断扩大，线性粒子加速器市场规模从 2024 年到 2032 年的复合年增长率预计将达到 5.9%。包括癌症治疗中心和研究机构在内的医疗保健设施的发展和现代化正在推动对先进电子直线加速器直线加速器的需求。现有设施的新安装和升级增加了对多种最先进技术的需求。对科学和医疗基础设施的大量投资也将在市场成长中发挥重要作用。

线性粒子加速器产业分为产品类型、技术、处理类型、应用、最终用户和地区。

就技术而言，在医疗、工业和研究领域的多功能应用的推动下，电子领域的市场价值将在 2032 年实现利润丰厚的复合年增长率，以满足对精度和效率日益增长的需求。现代电子直线加速器可提供高精度的辐射传输，这对于需要精确剂量分布的应用至关重要。提供增强性能的技术进步，包括更好的光束品质、更高的能量水平和更有效率的操作，将推动该领域的成长。

在应用方面，肺癌领域的线性粒子加速器产业预计将从 2024 年扩大到 2032 年。凭藉先进的影像和治疗计划能力来提高有效性和安全性，这些加速器已成为肺癌管理中的宝贵工具。

从地区来看，由于癌症发生率上升以及医疗环境中对先进治疗技术的需求强劲增长，预计2024年至2032年亚太地区直线粒子加速器市场规模将出现良好增长。对医疗基础设施和医疗设施现代化的投资不断增加，正在推动先进粒子加速器用于诊断和治疗目的的采用。政府不断采取的开发和升级科学和医疗基础设施的措施将有助于增加区域产品需求。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 对放射治疗的需求不断增长
    • 提高对早期癌症诊断和治疗的认识
    • 先进放射疗法的批准不断增加
    • 放疗优惠报销政策
  • 产业陷阱与挑战
    • 线性粒子加速器的高成本
    • 与辐射暴露相关的安全问题
• 成长潜力分析
• 未来市场趋势
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

• 主要趋势
• 高能机
• 中能量机
• 低耗能机

第 6 章：市场估计与预测：按技术分类，2021 - 2032 年

• 主要趋势
• X射线
• 电子
• 质子
• 离子束
• 其他技术

第 7 章：市场估计与预测：按治疗类型，2021 - 2032 年

• 主要趋势
• 传统直线粒子加速器
• 立体定位放射外科及立体定位全身放射治疗
• 调强放射治疗
• 容积调製电弧疗法
• 影像导引放射治疗
• 其他治疗类型

第 8 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 摄护腺癌
• 乳癌
• 肺癌
• 大肠直肠癌
• 头颈癌
• 其他应用

第 9 章：市场估计与预测：按最终用户分类，2021 - 2032 年

• 主要趋势
• 医院
• 放射科诊所
• 其他最终用户

第 10 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 11 章：公司简介

• AccSys Technology, Inc.
• Accuray Incorporated
• Altair Technologies, Inc.
• Brainlab AG
• Carl Zeiss Meditec AG
• Elekta
• Laird Technologies, Inc.
• MITSUBISHI HEAVY INDUSTRIES, LTD.
• Panacea Medical Technologies Pvt. Ltd.
• S.I.T. Sordina IORT Technologies S.p.A.
• SHINVA MEDICAL INSTRUMENT CO., LTD.
• Siemens Healthineers AG
• Varian Medical Systems, Inc.
• VIEWRAY TECHNOLOGIES, INC.
• VIVIRAD S.A.

Linear Particle Accelerators Market size is poised to record 5.9% CAGR from 2024-2032, on account of expanding usage in radiation-based technologies, including medical imaging, radiation therapy, and industrial processing. The development and modernization of healthcare facilities, including cancer treatment centers and research institutions, are driving the demand for advanced electron linacs linear accelerators. New installations and upgrades to the existing facilities are increasing the need for several state-of-the-art technologies. Significant investments in scientific and healthcare infrastructure will also play an important role in the market growth.

The linear particle accelerators industry is segmented into product type, technology, treatment type, application, end-user, and region.

In terms of technology, the market value from the electron segment will witness lucrative CAGR through 2032, driven by versatile applications in medical, industrial, and research fields to meet the increasing need for precision and efficiency. Modern electron linacs offer high precision in radiation delivery, which is crucial for applications requiring accurate dose distribution. Technological advancements to offer enhanced performance, including better beam quality, higher energy levels, and more efficient operation will push the segment growth.

With respect to application, the linear particle accelerators industry from the lung cancer segment is expected to expand from 2024 to 2032. The growth can be attributed to the rising need to offer precise, high-dose radiation delivery with minimal impacts on surrounding healthy tissues. With advanced imaging and treatment planning capabilities to enhance effectiveness and safety, these accelerators have emerged as valuable tools in the management of lung cancer.

Regionally, the Asia Pacific linear particle accelerators market size is expected to observe decent growth from 2024 to 2032, due to the rising incidence of cancer and strong growing demand for advanced treatment technologies in medical settings. The rising investments in healthcare infrastructure and modernization of medical facilities is boosting the adoption of advanced particle accelerators for diagnostic and therapeutic purposes. Growing government initiatives for developing and upgrading scientific and medical infrastructure will contribute to the regional product demand.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing demand for radiotherapy treatments
    • 3.2.1.2 Increasing awareness towards early cancer diagnosis and treatment
    • 3.2.1.3 Growing approvals for advanced radiotherapies
    • 3.2.1.4 Favourable reimbursement policies for radiotherapies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated to linear particle accelerator
    • 3.2.2.2 Safety concerns related to radiation exposure
• 3.3 Growth potential analysis
• 3.4 Future market trends
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 High-energy machine
• 5.3 Medium-energy machine
• 5.4 Low-energy machine

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 X-Ray
• 6.3 Electron
• 6.4 Proton
• 6.5 Ion beam
• 6.6 Other technologies

Chapter 7 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Conventional linear particle accelerator
• 7.3 Stereotactic radiosurgery & stereotactic body radiotherapy
• 7.4 Intensity-modulated radiation therapy
• 7.5 Volumetric modulated arc therapy
• 7.6 Image-guided radiation therapy
• 7.7 Other treatment types

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Prostate cancers
• 8.3 Breast cancers
• 8.4 Lung cancers
• 8.5 Colorectal cancers
• 8.6 Head & neck cancers
• 8.7 Other applications

Chapter 9 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Radiology clinics
• 9.4 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

• 11.1 AccSys Technology, Inc.
• 11.2 Accuray Incorporated
• 11.3 Altair Technologies, Inc.
• 11.4 Brainlab AG
• 11.5 Carl Zeiss Meditec AG
• 11.6 Elekta
• 11.7 Laird Technologies, Inc.
• 11.8 MITSUBISHI HEAVY INDUSTRIES, LTD.
• 11.9 Panacea Medical Technologies Pvt. Ltd.
• 11.10 S.I.T. Sordina IORT Technologies S.p.A.
• 11.11 SHINVA MEDICAL INSTRUMENT CO., LTD.
• 11.12 Siemens Healthineers AG
• 11.13 Varian Medical Systems, Inc.
• 11.14 VIEWRAY TECHNOLOGIES, INC.
• 11.15 VIVIRAD S.A.